Myocyte destruction in inflammatory cardiomyopathy - Apoptosis or necrosis?;Zelluntergang bei entzundlichen herzmuskelerkrankungen - Apoptose oder nekrose?

Herz

Volumn 24, Issue 3, 1999, Pages 211-218

  Pankuweit, Sabine ^a   Jobmann, Matthias ^b   Crombach, Marlies ^b   Portig, Irene ^b   Alter, Peter ^b   Kruse, Thorsten ^b   Hufnagel, Günter ^b   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Klinikum der Universität ^*

Author keywords

Apoptosis; Dilated cardiomyopathy; Inflammatory heart disease; Myocarditis; Necrosis; TUNEL assay

Indexed keywords

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; CARDIOMYOPATHY; CELL DEATH; DIAGNOSTIC VALUE; GEL ELECTROPHORESIS; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOCARDITIS; REVIEW; ANIMAL; HEART INFARCTION; HEART MUSCLE; NECROSIS; NICK END LABELING; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; CELL DEATH; HUMANS; IN SITU NICK-END LABELING; MYOCARDIAL INFARCTION; MYOCARDITIS; MYOCARDIUM; NECROSIS;

EID: 0033129712     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Berke G. Debate: The mechanism of lymphocyte-mediated killing. Lymphocyte-triggered internal target disintegration. Immunol Today 1991;12:396-9, discussion 402.
2. Cai W, Devaux B, Schaper W, et al. The role of Fas/APO1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 1997;131:177-86.
3. Cheng W, Li B, Kajstura J. Stretch-induced programmed myocyte cell death. J Clin Invest 1996;96:2247-59.
4. Cleveland JL, Ihle JN. Contenders in FasL/TNF death signalling. Cell 1995;81:479-82.
5. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-30.
6. Curnow SJ, Glennie MJ, Stevenson GT. The role of apoplosis in antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother 1993;36:149-55.
7. Davies MJ. Apoptosis in cardiovascular disease. Heart 1997;77: 498-501.
8. Fraser A, Evan G. A licence to kill. Cell 1996;85:781-4.
9. Freude B, Masters TN, Kostin S, et al. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol 1998;93:85-9.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
11. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994;90:556-73.
12. Keilholz U, Dummer R, Welters H, et al. A modified cytotoxicity assay with high sensitivity. Scand J Clin Lab invest 1990;50: 879-84.
13. Kajstura J, Cheng W, Reiss K. Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest 1996;94:1621-8.
14. Krahenbuhl O, Tschopp J. Debate: the mechanism of lymphocyte-mediated killing. Pcrforin-induced pore formation. Immunol Today 1991;12:399-402, discussion 403.
15. MacLellan WR, Schneider M. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997;81: 137-44.
16. Mallat Z, Tedgui A, Fontaliran F, et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;336:1190-6.
17. Meinl E, Fickenscher H, Thome M, et al. Anti-apoptotic strategies of lymphotropic viruses. Immunol Today 19;10:474-9.
18. Nagata S, Goldstein P. The Fas death factor. Science 1995;267: 1449-56.
19. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;336:1182-9.
20. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
21. Oltvai ZN, Milliman CL, Korsmeyer SJ. BCL-2 homodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
22. Prigent P, Blanpied C, Aten J, et al. A safe and rapid method for analyzing apoptosis-induced fragmentation of DNA extracted from tissues or cultured cells. J Immunol Methods 1993;160: 139-40.
23. Sanderson CJ. The mechanism of lymphocyte-mediated cytotoxicity. Biol Rev Camb Philos Soc 1981;56:153-97.
24. Saraste A, Pulkki K, Kallajoki M, et al. Apoptosis in human myocardial infarction. Circulation 1997;95:320-3.
25. Savill JS, Wyllie AH, Henson JE, et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-75.
26. Sedlak TW, Oltvai ZN, Yang E, et al. Multiple Bcl-2 family members demonstrate selective dimerixation with Bax. Proc Natl Acad Sci USA 1995;92:7834-8.
27. Szabolcs M, Michler RE, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 1996;94:1665-73.
28. Teiger E, Than VD, Richard L. Apoptosis in pressure overloaded heart induced hypertrophy in the rat. J Clin Invest 1996;97:2891.
29. Van Furth R, Van Zwei TL. Immunocytochemical detection of 5-bromo-2-deoxyuridine incorporation in individual cells. J Immunol Methods 1988;108:45-51.
30. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284:555-6.
31. Yeh ETH. Life and death in the cardivascular system. Circulation 1997;95:782-6.